These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 285861)

  • 21. [Continual and periodic treatment of patients with chronic granulocytic leukemia].
    Colović M; Petrović M; Jancić MS; Banićević B; Vucić Lj; Janosević S; Ristić M
    Srp Arh Celok Lek; 1984 Apr; 112(4):487-93. PubMed ID: 6595809
    [No Abstract]   [Full Text] [Related]  

  • 22. Cholestatic jaundice following treatment of chronic granulocytic leukemia with busulphan.
    Underwood JC; Shahani RT; Blackburn EK
    J Clin Pathol; 1970 Dec; 23(9):827. PubMed ID: 5278972
    [No Abstract]   [Full Text] [Related]  

  • 23. Jaundice after treatment of leukemia with busulphan.
    Underwood JC; Shahani RT; Blackburn EK
    Br Med J; 1971 Mar; 1(5748):556-7. PubMed ID: 5280623
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chronic granulocytic leukaemia (CGL): results of continuous busulphan mono-chemotherapy in 160 cases (1960-1980) (author's transl)].
    Sánchez Fayos J; Outeiriño J; de Villalobos E; Valera M; Alonso M; Calabuig MT; Paniagua G
    Sangre (Barc); 1981; 26(1):65-71. PubMed ID: 6942520
    [No Abstract]   [Full Text] [Related]  

  • 25. Cytochemical variants of neutrophil leukocyte populations in chronic myelocytic leukaemia. A microspectrophotometric study of the change in the periodic acid-Schiff (PAS) reaction in blood and bone marrow neutrophils during busulfan treatment.
    Gahrton G; Brandt L; Franzén S; Nordén A
    Scand J Haematol; 1969; 6(6):365-72. PubMed ID: 4190430
    [No Abstract]   [Full Text] [Related]  

  • 26. Pregnancy in a patient receiving busulphan for chronic myeloid leukaemia.
    Norhaya MR; Cheong SK; Hamidah NH; Ainoon O
    Singapore Med J; 1994 Feb; 35(1):102-3. PubMed ID: 8009265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron stores in chronic granulocytic leukaemia at presentation.
    Cervantes F; Rozman C; Brugues R; Llanas I
    Scand J Haematol; 1984 May; 32(5):469-74. PubMed ID: 6587557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Course and prognosis of chronic myeloid leukemia treated with busulfan. Study of 300 cases].
    Ionescu V
    Dtsch Med Wochenschr; 1971 May; 96(20):867-70. PubMed ID: 5280862
    [No Abstract]   [Full Text] [Related]  

  • 29. Econometric analysis of phase duration for blood morphology and basophil count alterations in chronic granulocytic leukaemia.
    Gola A; Smakowska E; Waszkiewicz L; Błaczkowska A; Kin-Dittmann I; Zielińska K; Czajkowska B; Pajsert E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):271-5. PubMed ID: 6205949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple antibody response following busulfan therapy.
    Spitler L; Fudenberg HH
    Vox Sang; 1970 May; 18(5):450-8. PubMed ID: 4195319
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro drug sensitivity studies of CFUc in chronic myelocytic leukemia: I. Suicide indices and busulfan sensitivity determinations during the chronic phase.
    Preisler HD; Kirshner J
    Exp Hematol; 1983 Aug; 11(7):618-25. PubMed ID: 6576910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Busulphan haemorrhagic cystitis.
    Millard RJ
    Br J Urol; 1978 May; 50(3):210. PubMed ID: 288495
    [No Abstract]   [Full Text] [Related]  

  • 33. Chronic myeloid leukaemia in Zambians.
    Lowenthal MN
    Trop Geogr Med; 1975 Jun; 27(2):132-6. PubMed ID: 1058559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Portal hypertension in a patient with chronic myeloid leukaemia.
    Foadi MD; Shaw S; Paradinas FJ
    Postgrad Med J; 1977 May; 53(619):267-9. PubMed ID: 267281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged survival in chronic granulocytic leukaemia after busulphan induced hypoplasia and karyotype conversion.
    Bennett M; Lewis D; Walker H
    Br J Haematol; 1985 Apr; 59(4):738-40. PubMed ID: 3857075
    [No Abstract]   [Full Text] [Related]  

  • 36. [Indirubin in the treatment of chronic myelocytic leukemia (CML)--estimation of labelling index of bone marrow cells by 3H-TdR].
    You YC; Mi JX; Wan JH; Yang TY; Wang ZC; Qian LS
    Zhonghua Zhong Liu Za Zhi; 1987 Nov; 9(6):418-20. PubMed ID: 3482992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The treatment of chronic granulocytic leukaemia.
    Canellos GP
    Clin Haematol; 1977 Feb; 6(1):113-28. PubMed ID: 334404
    [No Abstract]   [Full Text] [Related]  

  • 38. [Varying course of pancytopenia after busulfan treatment of chronic myelocytic leukemia (CML)].
    Krug K; Stenzel L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(2):181-7. PubMed ID: 79522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Observations on the therapy of chronic granulocytic leukaemia (C.G.L.) in adults.
    Das KV; Thomas M; Pilla MV; Vijayakumar
    J Assoc Physicians India; 1977 Aug; 25(8):547-53. PubMed ID: 275251
    [No Abstract]   [Full Text] [Related]  

  • 40. Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantation.
    Schuler US; Renner UD; Kroschinsky F; Johne C; Jenke A; Naumann R; Bornhäuser M; Deeg HJ; Ehninger G
    Br J Haematol; 2001 Sep; 114(4):944-50. PubMed ID: 11564090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.